Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

NCT05635708

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center Mskcc New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View all 61 locations
View Trial Details
Active, Not Recruiting

A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY

NCT05735327

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Dolnoslskie Centrum Onkologii, Pulmonologii i Hematologii Wroclaw, Dolnoslskie, Poland
  • Szpital Kliniczny im. Heliodora Swiecickiego UM wPoznaniu. Poznan, Greater Poland Voivodeship, Poland
  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu Poznan, Greater Poland Voivodeship, Poland
  • Centrum Onkologii im.Prof. F. Lukaszczyka w Bydgoszczy Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
View Trial Details
Active, Not Recruiting

A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery

NCT05872763

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China
  • Beijing Chest Hospital Beijing, China
  • Sichuan Provincial Cancer Hospital Chengdu, China
  • Harbin Medical University Cancer Hospital Harbin, China
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

NCT06099782

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • Russell Medical ( Site 0160) Alexander City, Alabama, United States
  • Alaska Oncology and Hematology ( Site 0121) Anchorage, Alaska, United States
  • Highlands Oncology Group-Research Department ( Site 0133) Springdale, Arkansas, United States
  • Marin Cancer Care ( Site 0148) Greenbrae, California, United States
View all 45 locations
View Trial Details

Related conditions